Axis Direct is bullish on CARE has recommended buy rating on the stock with a target price of Rs 1722 in its research report dated May 18, 2017.
Axis Direct's research report on CARE
CARE’s net profit for the quarter grew by 8% YoY (down 45% QoQ) to Rs 38 cr on account of strong growth of 241 % YoY in Other income (primarily investment income) due to profits booked on maturity of certain investments made for a longer tenure. Rating income grew by 1.5% YoY in Q4 FY17 (6% in FY17) on account of an increase in both the volume of fresh debt rated (7.5% YoY) and surveillance exercises.
Considering the economic recovery and improvement in credit growth, we are positive on the rating business of CARE. We value CARE at a PE of 25x FY19E EPS of Rs 69 to arrive at a valuation of Rs 1722 per share. We reiterate our BUY rating on the stock.
For all recommendations, click here
Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.
The Great Diwali Discount!
Unlock 75% more savings this festive season. Get Moneycontrol Pro for a year for Rs 289 only.
Coupon code: DIWALI. Offer valid till 10th November, 2019 .